Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2025-12-24 @ 2:43 PM
NCT ID:
NCT03861559
Eligibility Criteria:
Inclusion Criteria:
* Has a 2-year history of seasonal allergic rhinitis
* Has a positive skin test response to a local seasonal allergen (current, or performed in investigator's office within the past year)
* Is in good health and free of any unstable, clinically-significant disease, other than allergic rhinitis, that would interfere with the study schedule or evaluation of seasonal allergic rhinitis
Exclusion Criteria:
* Women who are pregnant or breastfeeding
* Women of childbearing potential who are not using an acceptable form of birth control
* Has asthma that requires therapy with inhaled or systemic corticosteroids, cromolyn, or nedocromil
* Has significant renal, hepatic, neurologic, cardiovascular, hematologic, metabolic, cerebrovascular, respiratory, gastrointestinal, or other significant medical illness or disorder which, in the judgment of the investigator, could interfere with the study, or required treatment which might interfere with the study
* Is on immunotherapy with the exception of maintenance therapy
* Has a clinically significant upper respiratory or sinus infection
* Has used an investigational drug within the previous 30 days
* Has nasal structural abnormalities, including large nasal polyps and marked septal deviation, that significantly interfere with nasal air flow
* Has a history of multiple drug allergies or an allergy to antihistamines or corticoids
* Has dependence upon nasal, oral or ocular decongestants, or nasal topical antihistamines, in the opinion of the investigator
* Has rhinitis medicamentosa
* Is using of any chronic medication which could affect the course of seasonal allergic rhinitis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT03861559
Study Brief:
Protocol Section:
NCT03861559